Perindopril tab 2 mg and 4 mg: Brand change

Brand change Active

Perindopril is a long-acting ACE inhibitor. Your brand is changing from Apo-Perindopril to Coversyl.

Your new brand: Coversyl

We are advised that stocks of Apo-Perindopril (supplied by Apotex) may be exhausted during February. Accordingly, we have listed the Coversyl brand from 1 February 2021 to ensure a funded brand remains available.

Coversyl has the same active ingredient which is delivered to the body in the same way. This product will be supplied under provisional consent.

The Coversyl brand is listed and fully funded from 1 February 2021.

Packaging difference

Coversyl is currently supplied with packaging for the Canadian market. Medsafe have written to health professionals about the differences between the Canadian packaging and New Zealand's requirements.

Read the packaging letter on Medsafe's website (PDF)(external link)  

Apotex leaving the market

As Apotex is leaving New Zealand, we are arranging new suppliers for the medicines they had supplied.

Learn more about Apotex

Who to contact

If you take perindopril, ask your health care professional if you have any questions about this brand change. They know you and your clinical circumstances best. 

If you have any funding questions, email enquiry@pharmac.govt.nz